Belimumab is used with other medications to treat certain types of systemic lupus erythematosus (SLE or lupus; an autoimmune disease in which the immune system attacks healthy parts of the body such as joints, skin, blood vessels, and organs) in adults and children 5 years of age and older. Belimumab is in a class of medications called monoclonal antibodies. It works by blocking the activity of a certain protein in people with SLE. Belimumab may not work as well to treat African Americans who have SLE.
Belimumab comes as a powder to be mixed into a solution to be injected intravenously (into a vein) in adults and children 5 years of age and older. Belimumab also comes as a solution (liquid) in an autoinjector or prefilled syringe to inject subcutaneously (under the skin) in adults. When given intravenously, it is usually given over at least an hour by a doctor or nurse once every 2 weeks for the first three doses, and then once every 4 weeks. Your doctor will decide how often you are to receive belimumab intravenously based on your body's response to this medication. When given subcutaneously, it is usually given once weekly preferably on the same day each week.
You will receive your first subcutaneous dose of belimumab injection in your doctor's office. If you will be injecting belimumab injection subcutaneously by yourself at home or having a friend or relative inject the medication for you, your doctor will show you or the person who will be injecting the medication how to inject it. You and the person who will be injecting the medication should also read the written instructions for use that come with the medication.
Remove the autoinjector or prefilled syringe from the refrigerator and allow it to reach room temperature 30 minutes before you are ready to inject belimumab injection. Do not try to warm the medication by heating it in a microwave, placing it in warm water, or through any other method. The solution should be clear to opalescent and colorless to pale yellow. Call your pharmacist if there are any problems with the package or the syringe and do not inject the medication.
You may inject belimumab injection on the front of the thighs or anywhere on your stomach except your navel (belly button) and the area 2 inches around it. Do not inject the medication into skin that is tender, bruised, red, hard, or not intact. Choose a different spot each time you inject the medication.
Belimumab may cause serious reactions during and after you receive the medication. A doctor or nurse will watch you closely while you are receiving the infusion and after the infusion to be sure you are not having a serious reaction to the medication. You may be given other medications to treat or help prevent reactions to belimumab. Tell your doctor or nurse immediately if you experience any of the following symptoms that may occur during the intravenous infusion or the subcutaneous injection or for up to a week after you receive the medication: rash; itching; hives; swelling of the face, eyes, mouth, throat, tongue, or lips; difficulty breathing or swallowing; wheezing or shortness of breath; anxiousness; flushing; dizziness; fainting; headache; nausea; fever; chills; seizures; muscle aches; and slow heartbeat.
Belimumab helps control lupus but does not cure it. Your doctor will watch you carefully to see how well belimumab works for you. It may take some time before you feel the full benefit of belimumab. It is important to tell your doctor how you are feeling during your treatment.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with belimumab and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website Web Siteor the manufacturer's website to obtain the Medication Guide.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Before using belimumab,
Unless your doctor tells you otherwise, continue your normal diet.
If you miss an appointment to receive a belimumab infusion, call your doctor as soon as possible.
If you miss your subcutaneous dose of belimumab injection, inject the missed dose as soon as you remember it. Then, inject your next dose at your regularly scheduled time or continue weekly dosing based on the new day injected. Do not inject a double dose to make up for a missed one. Call your doctor or pharmacist if you need help to decide when to inject belimumab injection.
Belimumab may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
Some side effects can be serious. If you experience any of these symptoms or those listed in the HOW section, call your doctor immediately:
Belimumab may increase your risk of certain cancers. Studies have shown that people who received belimumab were more likely to die from various causes than those who did not take belimumab. Talk to your doctor about the risks of receiving this medication.
Belimumab may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online ( Web Site ) or by phone (1-800-332-1088).
Keep this medication in the package it came in, away from light, tightly closed, and out of reach of children. Do not shake autoinjectors or prefilled syringes that contains belimumab. Store belimumab injection in the refrigerator; do not freeze. Avoid exposure to heat. Syringes may be stored outside of the refrigerator (up to 30°C) for up to 12 hours if protected from sunlight. Do not use the syringes and do not place them back into the refrigerator if unrefrigerated for more than 12 hours. Discard any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. Web Site
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website ( Web Site) for more information if you do not have access to a take-back program.
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at Web Site. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Keep all appointments with your doctor.
Ask your pharmacist any questions you have about belimumab injection.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
Selected Revisions: July 15, 2019.